Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-11-18

Clinical Trial Update: Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating how erythropoietin administration affects stress responses in patients with polytrauma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Multiple Trauma | Phase 2 | Status: UNKNOWN